Latest Posts
The latest guides, provider updates, and clinical news on GLP-1 injections — reviewed by clinicians and updated weekly.
How to Join a Retatrutide Clinical Trial (2026 Guide)
Key Takeaways Why a Clinical Trial Is Your Only Legal Option If you are interested in retatrutide (developer code LY3437943), it is essential to…
Will Insurance Cover Retatrutide? What to Expect at Launch
Key Takeaways Why This Is a Pre-Launch Question Retatrutide (developer code LY3437943), developed by Eli Lilly and Company, has not been approved…
How Much Will Retatrutide Cost? Projected Pricing Analysis
Key Takeaways Retatrutide Is Not Yet Priced: Here’s Why That Matters Retatrutide (developer code LY3437943), developed by Eli Lilly and Company, is…
When Will Retatrutide Be FDA Approved? 2026-2028 Timeline
Key Takeaways Retatrutide’s Regulatory Status Right Now Before diving into projected dates, it’s essential to be clear about where things stand today.…
What Is Retatrutide? A 2026 Guide to Eli Lilly’s Triple Agonist
Key Takeaways Investigational Status: Please Read Before Continuing Retatrutide is not approved by the FDA or any other regulatory agency anywhere in…
Stopping Oral GLP-1s: What to Expect After You Discontinue
Key Takeaways Why This Question Matters So Much Discontinuing a GLP-1 medication is one of the most consequential decisions in the entire…
Diet and Lifestyle While Taking Oral GLP-1s
Key Takeaways How Oral GLP-1s Change Eating Patterns All three approved oral GLP-1 medications work through the same underlying hormone pathway —…
Traveling with Oral GLP-1 Medications: Complete Guide
Key Takeaways Why Oral GLP-1s Are Genuinely Easier to Travel With One of the most underrated advantages of oral GLP-1 medications over…
Adherence to Oral GLP-1s: Why Pills Aren’t Automatically Easier
Key Takeaways The Assumption: “A Pill Must Be Easier Than a Shot” It’s an intuitive assumption — pills seem simpler than self-injecting…
Foundayo Long-Term Results: What ATTAIN-1 Shows After 72 Weeks
Key Takeaways Why “Long-Term” Matters for a Weight-Loss Pill Short-term weight loss is relatively easy to achieve with almost any intervention. The…
Rybelsus vs Wegovy Pill: Should You Switch?
Rybelsus and the Wegovy pill are both oral tablets containing semaglutide, made by the same manufacturer, Novo Nordisk. But they’re approved for…
Wegovy Pill vs Wegovy Injection: Same Drug, Different Delivery
The Wegovy pill and injectable Wegovy share the exact same active ingredient — semaglutide — yet they’re taken completely differently, dosed at…
Foundayo vs Zepbound: Oral Pill vs Injection Comparison
Foundayo (orforglipron) and Zepbound (tirzepatide) represent two very different approaches to GLP-1-based weight management. Foundayo is a once-daily oral small-molecule that activates…
Oral vs Injectable GLP-1: Which Is Better for Weight Loss?
With Foundayo (orforglipron) and the Wegovy pill now on the market alongside long-established injectables like Wegovy and Zepbound, people starting GLP-1 therapy…
Foundayo vs Wegovy Pill: Which Oral GLP-1 Is Right for You?
For the first time, people considering a GLP-1 medication for weight loss can choose between two different oral options instead of defaulting…
Oral GLP-1 Contraindications: Who Should Not Take These Drugs
Boxed warning: Foundayo (orforglipron), Wegovy pill (oral semaglutide 25 mg), and Rybelsus (oral semaglutide 3/7/14 mg) all carry an FDA boxed warning…
Do Oral GLP-1s Cause Different Side Effects Than Injections?
Boxed warning: All FDA-approved GLP-1 receptor agonists — oral and injectable alike, including Foundayo (orforglipron), Wegovy pill (oral semaglutide 25 mg), Rybelsus…
Nausea from Oral GLP-1s: How to Manage It
Important: This article describes general tolerability approaches referenced in clinical trial literature and patient guidance materials. It is not medical advice and…
Foundayo Side Effects: Complete 2026 Safety Profile
Boxed warning: Foundayo (orforglipron) carries an FDA boxed warning for the risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), based…
Oral GLP-1 Side Effects: What to Expect from Foundayo, Wegovy Pill, and Rybelsus
Boxed warning: Foundayo (orforglipron), Wegovy pill (oral semaglutide 25 mg), and Rybelsus (oral semaglutide 3/7/14 mg) all carry an FDA boxed warning…